Dr Aimin Xu: "FGF21-based pharmacotherapy for obesity-related metabolic complications"
~ Eligible for PSL1000H/PSL2000H/PSL4000Y Course Seminar Attendance ~
Speaker: Aimin Xu, MD, MSc, PhD
Chair and Professor of Metabolic Medicine, Department of Pharmacology and Pharmacy, Department of Medicine, Director, State Key Laboratory of Pharmaceutical Biotechnology, Hong Kong University
Join Zoom Webinar: https://us06web.zoom.us/j/83144918484